Low Migraine Recurrence With Intranasal DHE

(MedPage Today) -- Intranasal INP104, dihydroergotamine mesylate (DHE) delivered by a novel investigational device, was associated with high rates of efficacy for first-treated migraine and low rates of migraine recurrence, research presented at...